Sequoia's David Poppe says the fund likes the tailwinds in health care but has tried to avoid the reimbursement risks.
For the majority of pharmaceutical companies, strong pipelines should offset the approaching patent cliff.
BankAtlantic and Ryan Beck struggle through tough times.
©2014 Morningstar Advisor. All right reserved.